Fulgent Genetics, Inc. Common Stock —— 季度财务报表 (NASDAQ:FLGT) | MetaTrader

展开完整图表

Financials

概览声明统计 Documents

每季度年度

Market Capitalization 550.03 M
Employee 1 315
Founded 2011
CEO Ming Hsieh
Website www.fulgentgenetics.com
Headquarter Delaware, United States
FIGI BBG00DR7LTG2
Industry 诊断与研究

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

市盈率

-7.25

市销率

1.9

Related tickers

	#	姓名	价格	24小时 %	7天 %	一个月 %	一年 %	市值	最近7天
	2425	CSTL Castle Biosciences, Inc. - Common stock	34.31 USD	+2.60%	+1.18%	+23.28%	+39.39%	1.05 B USD
	2509	ACRS Aclaris Therapeutics, Inc. - Common Stock	6.07 USD	+0.83%	-4.41%	+16.96%	+203.50%	893.50 M USD
	3000	PRE Prenetics Global Limited - Class A Ordinary Share	26.05 USD	+0.93%	+11.28%	+33.93%	+219.63%	439.57 M USD
	3291	MYGN Myriad Genetics, Inc. - Common Stock	3.20 USD	+0.63%	+1.91%	+11.89%	-61.31%	306.08 M USD